While a casual reading of the report may give an impression of a "just OK" result, I am quite excited by this better than expected outcome. To show in the first dosing trial such a significant effect is really very positive indeed.
Given the excellent safety profile, longer dosing, higher concentrations and combination therapies all offer the potential for enhanced efficacy down the track.
This one has the marks of a real winner.
I'm not one to normally spruik any share but get on this one ASAP.
great result from biotron, page-2
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.18M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.8¢ | $1.335K | 34.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1131315 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 330372 | 2 |
View Market Depth
| Last trade - 15.04pm 09/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |